|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM178422908 |
003 |
DE-627 |
005 |
20231223152059.0 |
007 |
cr uuu---uuuuu |
008 |
231223s2008 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2008.01.018
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0595.xml
|
035 |
|
|
|a (DE-627)NLM178422908
|
035 |
|
|
|a (NLM)18359275
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Hirai, Hiroki
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes
|b VAMP2 and NPY are new minor autoantigens
|
264 |
|
1 |
|c 2008
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 07.07.2008
|
500 |
|
|
|a Date Revised 20.10.2021
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a The four major autoantigens (IA-2, IA-2 beta, GAD65 and insulin) of type 1 diabetes are all associated with dense core or synaptic vesicles. This raised the possibility that other secretory vesicle-associated proteins might be targets of the autoimmune response in type 1 diabetes. To test this hypothesis 56 proteins, two-thirds of which are associated with secretory vesicles, were prepared by in vitro transcription/translation and screened for autoantibodies by liquid phase radioimmunoprecipitation. Two secretory vesicle-associated proteins, VAMP2 and NPY, were identified as new minor autoantigens with 21% and 9%, respectively, of 200 type 1 diabetes sera reacting positively. These findings add support to the hypothesis that secretory vesicle-associated proteins are particularly important, but not the exclusive, targets of the autoimmune response in type 1 diabetes. Selective screening of the human proteome offers a useful approach for identifying new autoantigens in autoimmune diseases
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, N.I.H., Intramural
|
650 |
|
7 |
|a Autoantibodies
|2 NLM
|
650 |
|
7 |
|a Autoantigens
|2 NLM
|
650 |
|
7 |
|a Neuropeptide Y
|2 NLM
|
650 |
|
7 |
|a Vesicle-Associated Membrane Protein 2
|2 NLM
|
700 |
1 |
|
|a Miura, Junnosuke
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hu, Yafang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Larsson, Helena
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Larsson, Karin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lernmark, Ake
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ivarsson, Sten-A
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wu, Tianxia
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kingman, Albert
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tzioufas, Athanasios G
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Notkins, Abner L
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 127(2008), 3 vom: 29. Juni, Seite 366-74
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:127
|g year:2008
|g number:3
|g day:29
|g month:06
|g pages:366-74
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2008.01.018
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 127
|j 2008
|e 3
|b 29
|c 06
|h 366-74
|